Origin Asset Management LLP Bristol Myers Squibb CO Transaction History

Origin Asset Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $1.91 Million - $2.24 Million	-32,300 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $53,406 - $60,065	-900 Reduced 2.71%	32,300 $2.04 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $2.49 Million - $2.76 Million	-43,400 Reduced 56.66%	33,200 $2 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $378,258 - $442,221	-6,900 Reduced 8.26%	76,600 $4.5 Million
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $4.5 Million - $6.54 Million	-97,000 Reduced 53.74%	83,500 $4.65 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $8.88 Million - $11.6 Million	180,500 New	180,500 $11.6 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Origin Asset Management LLP with notifications on news.